Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00691665Phase 4Completed
A Phase 4 trial of olopatadine in seasonal allergic rhinitis (SAR), sponsored by Alcon Inc.. Started May 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00691665.